
Drug Development
Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review
by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire,
by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire,
by Simona Portaro, MD, PhD; Giuseppa Maresca, PsyD; Antonio Raffa,
by Evelyne Baroud, MD; Roula Hourani, MD; and Farid Talih,
by Randy A. Sansone, MD, and Lori A. Sansone, MD
by Randy A. Sansone, MD, and Lori A. Sansone, MD